Hepatitis A and typhoid vaccine

Hepatitis A and typhoid vaccine is a combination vaccine to protect against the infectious diseases hepatitis A and typhoid. It is a combination of inactivated Hepatitis A virus and Vi polysaccharide of Salmonella typhi bacteria. Branded formulations include Hepatyrix from GlaxoSmithKline,[1][2] and ViVaxim[3][4][5][6][7] and ViATIM[8] from Sanofi Pasteur.[1][9]

Hepatitis A and typhoid vaccine
Combination of
Hepatitis AVaccine
TyphoidVaccine
Clinical data
Trade namesViVaxim, Hepatyrix, ViATIM
AHFS/Drugs.comUK Drug Information
Pregnancy
category
  • AU: B2
Routes of
administration		Intramuscular injection
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only)
Identifiers
CAS Number
ChemSpider
  • none

Society and culture

Brand names

The vaccine is distributed under various brand names in the European Union.[1]

References
  1. List of nationally authorised medicinal products. Active substance(s): hepatitis a (inactivated) / typhoid polysaccharide vaccine (adsorbed) (PDF) (Report). European Medicines Agency (EMA). Retrieved 18 October 2020.
  2. "Hepatyrix. Package Leaflet:Information for the user" (PDF). Drugs.com. Archived from the original (PDF) on 15 July 2018. Retrieved 15 July 2018.
  3. "VIVAXIM suspension and solution for suspension for injection in pre-filled syringe". Drugs.com. Archived from the original on 15 July 2018. Retrieved 15 July 2018.
  4. "Australian Product Information – Vivaxim (Salmonella typhi Vi polysaccharide and hepatitis A virus antigen) Vaccine" (PDF). Retrieved 18 October 2020.
  5. "Vivaxim Salmonella typhi vaccine; Hepatitis A vaccine". Retrieved 18 October 2020.
  6. "Vivaxim 1mL injection syringe composite pack". Therapeutic Goods Administration (TGA). Archived from the original on 19 October 2020. Retrieved 18 October 2020.
  7. "Summary for ARTG Entry: 82745 Vivaxim 1mL injection syringe composite pack" (PDF). Therapeutic Goods Administration (TGA). Retrieved 18 October 2020.
  8. "ViATIM suspension and solution for suspension for injection in pre-filled syringe". Drugs.com. Archived from the original on 15 July 2018. Retrieved 15 July 2018.
  9. "ViATIM suspension and solution for suspension for injection in pre-filled syringe - Summary of Product Characteristics (SmPC)". (emc). 3 September 2019. Retrieved 18 October 2020.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.